MiNK Therapeutics, Inc. (INKT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 0.9800 |
| Open | 0.9800 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.9405 - 1.0100 |
| 52-week range | 0.7500 - 3.3400 |
| Volume | |
| Avg. volume | 101,306 |
| Market cap | 32.641M |
| Beta (5Y monthly) | 0.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
This MiNK Therapeutics Insider Increased Their Holding In The Last Year
Viewing insider transactions for MiNK Therapeutics, Inc.'s ( NASDAQ:INKT ) over the last year, we see that insiders...
- Zacks
All You Need to Know About MiNK Therapeutics, Inc. (INKT) Rating Upgrade to Buy
MiNK Therapeutics, Inc. (INKT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Insider Monkey
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript March 21, 2024 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.15. INKT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day everyone, and welcome […]
© 2024 Yahoo. All rights reserved.